Immunological studies in neonates with spina bifida

Zeitschrift Fur Kinderchirurgie Und Grenzgebiete
|December 1, 1979
PubMed

Insights

Neonates with spina bifida show normal T and B lymphocyte subpopulations and mitogen responsiveness. This suggests no impairment of immune cell function in infants with this congenital condition.

Area of Science:

  • Immunology
  • Neonatal Medicine
  • Developmental Biology

Background:

  • Spina bifida is a complex congenital condition affecting newborns.
  • Assessing immune function in neonates with spina bifida is crucial for understanding their overall health.
  • Lymphocyte subpopulations and their responsiveness are key indicators of immune system status.

Purpose of the Study:

  • To investigate T and B lymphocyte subpopulations in neonates with spina bifida before surgical intervention.
  • To evaluate the mitogen responsiveness of lymphocytes in these neonates.
  • To compare immune parameters between neonates with spina bifida and healthy controls.

Main Methods:

  • Flow cytometry was used to analyze T and B lymphocyte subpopulations.
  • Phytohemagglutinin (PHA) was used as a mitogen to assess lymphocyte responsiveness.
  • Data from 15 neonates with spina bifida were compared to a control group of 30 healthy neonates.

Main Results:

  • The mean percentage of T-lymphocytes in spina bifida patients was 44.6%, compared to 48.9% in normal neonates.
  • A normal dose response to PHA was observed in all investigated patients.
  • No significant differences were noted in B-lymphocyte subpopulations between the groups.

Conclusions:

  • Neonates with spina bifida exhibit normal T and B lymphocyte subpopulations.
  • Lymphocyte function, as assessed by mitogen responsiveness, appears unimpaired in neonates with spina bifida.
  • These findings suggest that spina bifida does not inherently compromise early immune system development in neonates.